MAPK8IP3 and non-small cell lung carcinoma: The regulation of the MSTRG.292666.16/miR-6386-5p/MAPK8IP3 axis by exosomes derived from M2-like macrophages may potentially contribute to the development of resistance to Osimertinib in patients with non-small cell lung cancer (NSCLC)83.